Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |